Roche Dismisses Promega Lawsuit As Baseless
On Thursday, Promega said it had sued Hoffman-La Roche for overcharging the US government for products used for research and healthcare. Promega alleged that the overcharges included royalty payments to use a research enzyme called Taq based on a Roche patent, the subject of a legal dispute between the two companies.
Roche sued Promega in...
To view the full article, register now.